# Long-term Beta-blocker Therapy After Acute Myocardial Infarction

Study · id `cardio:ct-nct04769362` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04769362](<https://clinicaltrials.gov/study/NCT04769362>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04769362

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2540 participants.

## Technical summary

Registry record NCT04769362. Randomized; no masking; primary purpose treatment. Start 2021-05-04 (actual); primary completion 2026-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2540 participants (planned count; ClinicalTrials.gov record NCT04769362, source copy `cardio:ctgov-nct04769362-2025-12-29`, retrieved 2026-10-26)
- Started: 2021-05-04 (actual) (ClinicalTrials.gov record NCT04769362, source copy `cardio:ctgov-nct04769362-2025-12-29`, retrieved 2026-10-26)
- Primary completion: 2026-01-31 (anticipated) (ClinicalTrials.gov record NCT04769362, source copy `cardio:ctgov-nct04769362-2025-12-29`, retrieved 2026-10-26)
- Completion: 2026-03-31 (anticipated) (ClinicalTrials.gov record NCT04769362, source copy `cardio:ctgov-nct04769362-2025-12-29`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04769362, source copy `cardio:ctgov-nct04769362-2025-12-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04769362-2025-12-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Long-term Beta-blocker Therapy After Acute Myocardial Infarction
- Acronym: SMART-DECISION
- Condition: Myocardial Infarction
- Intervention (Drug): Discontinuation of β-blocker
- Lead sponsor: Samsung Medical Center
- Lead sponsor class: OTHER
- Collaborator: Kangbuk Samsung Hospital
- Collaborator class: OTHER
- Collaborator: Gyeongsang National University Hospital
- Collaborator class: OTHER
- Collaborator: Kyung Hee University Hospital
- Collaborator class: OTHER
- Collaborator: Keimyung University Dongsan Medical Center
- Collaborator class: OTHER
- Collaborator: Korea University Anam Hospital
- Collaborator class: OTHER
- Collaborator: Sejong General Hospital
- Collaborator class: OTHER
- Collaborator: Seoul National University Bundang Hospital
- Collaborator class: OTHER
- Collaborator: Samsung Changwon Hospital
- Collaborator class: OTHER
- Collaborator: Saint Vincent's Hospital, Korea
- Collaborator class: OTHER
- Collaborator: Presbyterian medical center
- Collaborator class: UNKNOWN
- Collaborator: Wonkwang University Hospital
- Collaborator class: OTHER
- Collaborator: Wonju Severance Christian Hospital
- Collaborator class: OTHER
- Collaborator: Ewha Womans University Seoul Hospital
- Collaborator class: OTHER
- Collaborator: Inje University Ilsan Paik Hospital
- Collaborator class: OTHER
- Collaborator: Chonbuk National University Hospital
- Collaborator class: OTHER
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Jeju National University Hospital
- Collaborator class: OTHER
- Collaborator: Chosun University Hospital
- Collaborator class: OTHER
- Collaborator: Chungbuk National University Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Discontinuation of Beta-Blocker Therapy after Myocardial Infarction (`cardio:pubmed-41910427`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 19 registry organizations

## Provenance

Content hash: 85383bd8354f83e3065e3c428e6f20ca72f9f45bbf92495edb4e3d8e2a14d14d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
